节点文献
N6-甲基腺嘌呤调控线粒体功能及其在代谢性疾病中的研究进展
N6-methyladenine regulates mitochondrial function and its research progress in metabolic diseases
【摘要】 N6-甲基腺嘌呤(6mA)是存在于真核生物中的表观遗传修饰,通过对线粒体DNA、非编码基因和核糖体DNA等进行修饰,进而动态调控转录。目前研究发现,6mA通过调节线粒体DNA的转录等影响线粒体活性和功能,进而参与代谢性疾病的发生发展。本文探讨6mA调控线粒体功能的机制及其在肥胖、动脉粥样硬化、高血压和癌症等代谢性疾病中的作用,有望为代谢相关疾病的防治提供新思路。
【Abstract】 N6-methyladenine(6 mA) is an epigenetic modification existed in eukaryotes, which dynamically regulates transcription by modifying mitochondrial DNA, non-coding genes and ribosomal DNA. Current studies have found that 6 mA affects mitochondrial activity and function by regulating mitochondrial DNA transcription, etc., and then participates in the occurrence and development of metabolic diseases. This paper discusses the mechanism of 6 mA regulating mitochondrial function and its role in metabolic diseases such as obesity, atherosclerosis, hypertension and cancer, which is expected to provide new ideas for the prevention and treatment of metabolic-related diseases.
【Key words】 N6-methyladenine; mitochondrial function; metabolic disease;
- 【文献出处】 中国动脉硬化杂志 ,Chinese Journal of Arteriosclerosis , 编辑部邮箱 ,2022年05期
- 【分类号】R589
- 【下载频次】154